Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology Jul 20;33(21):2353-2360
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID26077235
- PMC
- PMC4500829
- Study Number(s)
- E1199
Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer
- Journal / Conference
- European Hematology Association Annual Meeting (June 11-14, 2015, Vienna, Austria), poster;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106
Phase 1 Trial of G-CSF, cladribine, cytarabine, and dose-escalated mitoxantrone (G-CLAM) in adults with newly diagnosed AML or high-risk MDS
- Journal / Conference
- Journal of Acupuncture and Meridian Studies Jun;8(3):152-158
- Year
- 2015
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID26100070
- PMC
- PMC4705910
- Study Number(s)
- S1200
Methods to standardize a multicenter acupuncture trial protocol to reduce aromatase inhibitor-related joint symptoms in breast cancer patients
- Journal / Conference
- Blood, Nov 26;126(22):2475-2478
- Year
- 2015
- Research Committee(s)
- Myeloma
- PMID
- PMID26468228
- PMC
- PMC4661169
- Study Number(s)
- S0120
Prospective analysis of antigen-specific immunity, stem cell antigens and immune checkpoints in monoclonal gammopathy
- Journal / Conference
- Hematological Oncology 33: (Suppl S1, abst. 062), p.132; International Conference on Malignant Lymphoma (June 17-20, 2015, Lugano, Switzerland), oral;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1106
Results of a randomized phase II trial of R-HCVAD vs. R-bendamustine followed by autologous stem cell transplants for patients with mantle cell lymphoma: US intergroup study S1106
- Journal / Conference
- New England Journal of Medicine Jan 29;372(5):436-446
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25495490
- PMC
- PMC4341825
Adjuvant ovarian suppression in premenopausal breast cancer
- Journal / Conference
- Journal of Clinical Oncology Mar 1;33(7):701-708
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25605861
- PMC
- PMC4334774
- Study Number(s)
- N9831
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the north central cancer treatment group N9831 adjuvant trastuzumab trial
- Journal / Conference
- Haematololgica Mar;100(3):331-335
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25527568
- PMC
- PMC4349271
- Study Number(s)
- S0106, S0112, S0301, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9918
Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia
- Journal / Conference
- British Journal of Urology International Jul 116(1):44-49
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25413313
- PMC
- PMC4524781
- Study Number(s)
- 4B951
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial
- Journal / Conference
- Breast Cancer Research and Treatment Jan;149(2):439-448, 2015
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25552364